Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)
China flag China · Delayed Price · Currency is CNY
15.59
-0.13 (-0.83%)
Nov 13, 2024, 3:00 PM CST

Tasly Pharmaceutical Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
881.051,071-264.242,3591,1261,001
Upgrade
Depreciation & Amortization
493493517.95487.77539.67386.72
Upgrade
Other Amortization
23.1423.1414.7315.2350.3637.04
Upgrade
Loss (Gain) From Sale of Assets
-0.15-0.15-1.48-44.22-1.73-0.39
Upgrade
Asset Writedown & Restructuring Costs
1.781.78352.26265.4866.4153.93
Upgrade
Loss (Gain) From Sale of Investments
270.75270.751,158-1,682-355.07133.58
Upgrade
Provision & Write-off of Bad Debts
8.198.19-1.34-5.3565.46-0.65
Upgrade
Other Operating Activities
288.43-2.03-31.24123.82254.5467.6
Upgrade
Change in Accounts Receivable
1,2431,243535.511,231-397.93-22.82
Upgrade
Change in Inventory
-220.72-220.72-2.86-198.3756.58-153.85
Upgrade
Change in Accounts Payable
-395.35-395.3536.56243.78324.51-246.2
Upgrade
Change in Other Net Operating Assets
67.7667.7611.013.4415.1717.15
Upgrade
Operating Cash Flow
2,6762,5762,2802,8011,7911,680
Upgrade
Operating Cash Flow Growth
17.00%12.98%-18.62%56.39%6.61%12.48%
Upgrade
Capital Expenditures
-642.66-668.82-404.41-571.73-408.81-730.78
Upgrade
Sale of Property, Plant & Equipment
10.421.191.3468.926.31.45
Upgrade
Cash Acquisitions
30.94---147.31--0.48
Upgrade
Divestitures
---424.19734.01-1.31
Upgrade
Investment in Securities
-1,308-134.14-919.91126.4239.33151.69
Upgrade
Other Investing Activities
-1,400-1,30756.7556.7689.976.66
Upgrade
Investing Cash Flow
-3,309-2,109-1,266-42.83865.86-492.98
Upgrade
Short-Term Debt Issued
-213.91102.79157.3111.89
Upgrade
Long-Term Debt Issued
-1,8172,7111,4414,9374,275
Upgrade
Total Debt Issued
1,7942,0312,8141,4424,9944,387
Upgrade
Short-Term Debt Repaid
--127-9.87-82.14-82.72-79.67
Upgrade
Long-Term Debt Repaid
--1,345-2,311-2,717-6,308-5,820
Upgrade
Total Debt Repaid
-2,501-1,472-2,321-2,799-6,391-5,900
Upgrade
Net Debt Issued (Repaid)
-707.01559.55492.71-1,358-1,397-1,513
Upgrade
Repurchase of Common Stock
---60.8-56.43-94.76-12.88
Upgrade
Common Dividends Paid
-546.7-563.22-553.97-610.49-799.29-903.58
Upgrade
Other Financing Activities
-651.3-1,193-114.58-458.73-20.1239.92
Upgrade
Financing Cash Flow
-1,905-1,196-236.63-2,483-2,311-2,390
Upgrade
Foreign Exchange Rate Adjustments
-2.27-1.2630.391.94-12.153.85
Upgrade
Net Cash Flow
-2,540-730.54807.36276.97334.16-1,198
Upgrade
Free Cash Flow
2,0331,9071,8752,2291,382949.37
Upgrade
Free Cash Flow Growth
14.99%1.68%-15.89%61.28%45.61%33.02%
Upgrade
Free Cash Flow Margin
23.74%21.98%21.71%28.04%10.18%5.00%
Upgrade
Free Cash Flow Per Share
1.361.281.281.480.920.63
Upgrade
Cash Interest Paid
--4.05-0.20.35
Upgrade
Cash Income Tax Paid
975.881,0991,1061,0081,1121,255
Upgrade
Levered Free Cash Flow
1,7991,3481,5172,5315,668315.77
Upgrade
Unlevered Free Cash Flow
1,8461,3991,5572,5805,847597.69
Upgrade
Change in Net Working Capital
-1,121-652.27-591.03-1,872-4,798250.2
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.